Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Serine protease 38 (PRSS38) is a member of the serine-type endopeptidase (protease) family, encoded by the PRSS38 gene in humans as well as orthologs in mouse (Prss38) and rat (Prss38). It is predicted to catalyze the hydrolysis of peptide bonds in a range of biological processes, including general proteolysis, by acting in the extracellular region. Its enzymatic function is based on a characteristic serine residue in the active site. The gene is expressed in multiple tissues and is under investigation for its expression in various cancer types, though its precise physiological and disease roles are still being determined. There are no known approved drugs or therapeutic agents targeting this molecule, and it has no established use as a biomarker as of current evidence.
Null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serine protease 38 (PRSS38).